glp-1 for binge eating GLP-1s may reduce and similar behaviours in people living with obesity, suggests the most comprehensive systematic review and meta-analysis to date, published in eClinicalMedicine. Find out more 👉 http://spkl.io/61897yUsZ Figure Novel potential pharmacological approaches in

Nous privilgions des formats pratiques, discrets, sans excipients superflus

The results reported a 6.0%, 6.8%, 9.1%, 9.7%, and 10.8% decrease in body weight for the groups receiving cagrilintide in doses of 0.3 mg, 0.6 mg, 1.2 mg, 2.4 mg, and 4.5 mg, respectively [1]

Quality sourcing and clinician oversight matter

The Pro-Gly-Pro (PGP) addition is a stabilising motif that protects against enzymatic degradation and increases half-life

Patients who travel frequently or prefer not to visit a clinic weekly often choose subcutaneous for this reason

Research has demonstrated that curcumin modulates several circRNAs, including circ-HN1, circ-PRKCA, circPLEKHM3, circZNF83, circFNDC3B, circ_KIAA1199, circRUNX1, circ_0078710, and circ_0056618